Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
341. |
ECCT/20/08/04 | LOW DOSE RADIATION THERAPY A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) in the treatment of severe Covid 19 pneumonia patients on (or requiring) mechanical ventilatory support |
Principal Investigator(s) 1. PROF. MANSOOR SALEH Site(s) in Kenya Aga Khan University Hospital, Nairobi |
11-11-2020 |
View |
342. |
ECCT/21/02/01 | PTSD 102 TONIX A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants with PTSD Taken Daily at Bedtime (Protocol No. TNX-CY-P308). |
Principal Investigator(s) 1. Prof. Lukoye Atwoli Site(s) in Kenya 1. Moi Teaching and Referral Hospital/Moi University (Uasin Gishu county) 2. KEMRI Nairobi (Nairobi City county) 3. Aga Khan University Hospital (Nairobi City county) |
16-06-2021 |
View |
343. |
ECCT/20/09/06 | Schisto RDT evaluation A performance evaluation of a prototype rapid diagnostic test for the diagnosis of schistosomiasis |
Principal Investigator(s) 1. Sammy Njenga Site(s) in Kenya Kenya Medical Research Institute (KEMRI) |
01-12-2020 |
View |
344. |
ECCT/15/12/02 | The Evidence for Contraceptive options and HIV Outcomes (ECHO) Trial A Multi Centre, Open label, Randomized Clinical Trial, Comparing HIV incidence and Contraceptive Benefits in Women using Depot Medroxyprogesterone Acetate, Levernogestrel (LNG) implant and Copper Intrauterine Devices (IUD). Short Title : The Evidence for Contraceptive options and HIV Outcomes (ECHO) Trial |
Principal Investigator(s) 1. Prof Elizabeth Anne Bukusi Site(s) in Kenya KEMRI-RCTP Study center , Lumumba |
11-04-2016 |
View |
345. |
ECCT/21/09/04 | Recombinant COVID-19 Vaccine A global multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to evaluate the efficacy, safety, and immunogenicity of recombinant COVID-19 vaccine (Sf9 cells) for the prevention of COVID-19 in adults aged 18 years and older |
Principal Investigator(s) 1. Sylvester Kimaiyo Site(s) in Kenya 1. KAVI-Institute of Clinical Research (Nairobi City county) 2. Moi Teaching and Referral Hospital (Uasin Gishu county) 3. Kenya Medical Research Institute, Kilifi (Kilifi county) |
17-09-2021 |
View |
346. |
ECCT/23/05/04 | PRIORITY Trial Prevention of Iron Deficiency Anemia Post-delivery |
Principal Investigator(s) 1. FABIAN OMODING ESAMAI 2. PAUL OBANDA NYONGESA Site(s) in Kenya BUSIA COUNTY REFERRAL HOSPITAL |
18-09-2023 |
View |
347. |
ECCT/22/04/02 | GO42144 A PHASE Ia/Ib DOSE-ESCALATION AND DOSE- EXPANSION STUDY EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITYOF GDC-6036 AS A SINGLE AGENT AND IN COMBINATION WITH OTHER ANTI-CANCER THERAPIES IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS WITH A KRAS |
Principal Investigator(s) 1. Mansoor Noorali Saleh Site(s) in Kenya Aga Khan University, Nairobi |
19-08-2022 |
View |
348. |
ECCT/13/10/03 | The Impact of Supplementation with Iron and Vitamin B12 Singly and In Combination on Nutritional Status and Morbidity Among Primary School Children. |
Principal Investigator(s) 1. Priscilla Monyangi Dr. Nyakundi Site(s) in Kenya Kilifi County, Ganze District. |
02-02-2013 |
View |
349. |
ECCT/17/06/02 | PAINT Study A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral-naïve HIV-1 infected adolescents and children aged ≥6 to <18 years |
Principal Investigator(s) 1. Isaac Tsikhutsu Site(s) in Kenya 1. Kenya Medical Research Institute/Walter Reed Project, HIV Program (Kericho county) 2. KAVI Institute of Clinical Research (Nairobi City county) |
10-10-2017 |
View |
350. |
ECCT/18/08/01 | NOVICE-M Trial NOn-invasive Ventilation In Children with CErebral Malaria Trial |
Principal Investigator(s) 1. Professor Kathryn Maitland Site(s) in Kenya Kilifi County Hospital |
05-04-2019 |
View |